Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

by Impulse Dynamics | Mar 28, 2025 | Press Releases

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization MARLTON, N.J., March 28,...

Impulse Dynamics Expands Executive Leadership Team

by Impulse Dynamics | Sep 24, 2024 | Press Releases

Extensive depth of experience comes with new leaders – Chief Operating Officer, Chief Financial Officer, Chief Administrative Officer and Chief Science and Strategy Officer MARLTON, N.J., September 24, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical...

Impulse Dynamics Surpasses 10,000 Patients Benefiting from CCM® Therapy for Heart Failure

by Impulse Dynamics | May 13, 2024 | Press Releases

Milestone Highlights Transformative Symptom Management for Patients Living with Heart Failure MARLTON, N.J., May 13, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced...

Impulse Dynamics Completes $136M Financing Round

by Impulse Dynamics | Feb 14, 2024 | Press Releases

Continued Progress Earns Financing to AccelerateCommercial Growth and Advancing Pipeline MARLTON, N.J., February 14, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is...

Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System

by Impulse Dynamics | Oct 30, 2023 | Press Releases

Reflecting Company Commitment to Innovation in Support of Patient Need MARLTON, N.J., October 30, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has...